Loading page

Author: Ed Silverman

Ed Silverman has ^84.3% among authors. BS Score: 7.4%. Articles analyzed: 2. Words analyzed: 1,200.

Top reasoning patterns

Framing Effect - 44.7% (536 hits)
Biased Writer Voice - 24.3% (291 hits)
Negativity Bias - 9.4% (113 hits)
Quote-first Misdirection - 6.5% (78 hits)
Hasty Generalization - 5.3% (64 hits)
Confirmation Bias - 3.8% (46 hits)
Appeal to Authority - 3.7% (44 hits)
Begging the Question - 3.7% (44 hits)

Analyzed articles

Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitals ^49.6%

STAT - By Ed Silverman - 7/2/2026, 7:52 PM

Hasty Generalization 41.3% - Framing Effect 33.5% - Biased Writer Voice 33.5%

Dozens of congressional lawmakers are urging the Trump administration to force Eli Lilly to reinstate mandated price breaks to hospitals that participate in a federal drug discount program but have refused to provide the company with claims data. In a letter to Department of Health and Human Services Secretary Robert F. Kennedy Jr., the... more

U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drug ^77.7%

STAT - By Ed Silverman - 7/2/2026, 12:54 PM

Biased Writer Voice 78.6% - Framing Effect 59.3% - Negativity Bias 32.4%

In a victory for the pharmaceutical industry, a federal judge blocked a Colorado state panel from placing a cap on the price of a blockbuster drug sold by Amgen after deciding the company is “likely to be significantly harmed.” The ruling pauses a controversial, first-in-the-nation move by the Colorado Prescription Drug Affordability... more

React failed to load. Check your network or content security policy, then refresh.

Author: Ed Silverman

Top reasoning patterns

Analyzed articles

Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitals 49.6%

U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drug 77.7%

Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitals ^49.6%

U.S. judge blocks Colorado’s first-of-its-kind price cap on an Amgen drug ^77.7%